Medworld医疗世界为您提供准确、及时、有用的医疗器械行业及医疗圈的市场动态，产品信息，技术进展等资讯！来源：MDDI by Omar FordStryker has thrown in its bid to acquire one of the 25 most attractive medtech companies on the M&A radar. The Kalamazoo, MI-based company said it was acquiring K2M, a specialist in complex spine and minimally invasive, in a transaction $1.4 billion.Specifics of the deal show that Stryker has agreed to acquire all of the issued and outstanding shares of common stock of K2M in an all cash transaction for $27.50 per share.The purchase price represents a 27% premium over K2M’s average closing price during the 90 trading days ended Aug. 29, 2018. The deal is slated to close in late 4Q18.The move would help boost Stryker’s spinal division.“This acquisition underscores our commitment to the spinal market, whic
………………………………
